LNTH — Lantheus Holdings, Inc.
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 1521036 ·
Last close
$99.74
Market Cap
$6.51B
52W High
$111.86
52W Low
$49.67
ADV30
1,135,640
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 388,180,000 | 241,855,000 | 100,215,000 | 75,029,000 | 2,414,662,000 | 593,298,000 | 1,102,884,000 |
| Mar 2026 | 377,333,000 | 230,922,000 | 81,326,000 | 118,417,000 | 2,346,587,000 | 498,582,000 | 1,134,299,000 |
| Dec 2025 | 406,786,000 | 240,875,000 | 77,184,000 | 54,088,000 | 2,227,399,000 | 359,121,000 | 1,137,602,000 |
| Sep 2025 | 384,014,000 | 222,366,000 | 43,615,000 | 27,771,000 | 2,276,400,000 | 382,006,000 | 1,157,194,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$412,802,000
Investing CF
$-307,015,000
Financing CF
$-207,070,000
CapEx
$-24,971,000
Dividends Paid
—
Buybacks
$-200,017,000
EPS Diluted TTM
$4.14
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$872,950,000
Inventory
$57,551,000
Receivables
$354,056,000
ST Investments
—
EBIT TTM
$382,783,000
Pretax Income TTM
$362,976,000
Interest Exp TTM
$19,807,000
Analysts
9
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,556,312,960
EBITDA
$392,224,992
Free Cash Flow
$451,656,000
Enterprise Value
$6,575,215,104
Total Cash
$593,297,984
Total Debt
$624,958,016
Shares Out
65,299,875
Trailing EPS
$4.18
Book Value
$20.10
ROE
22.2%
ROA
8.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,541,609,000 | 315,559,000 | 233,559,000 | 2,227,399,000 | 1,137,602,000 | 1,089,797,000 | 390,141,000 |
| Dec 2024 | 1,533,910,000 | 448,564,000 | 312,442,000 | 1,980,340,000 | 892,329,000 | 1,088,011,000 | 544,750,000 |
| Dec 2023 | 1,296,429,000 | 364,642,000 | 326,661,000 | 1,651,149,000 | 835,257,000 | 815,892,000 | 305,260,000 |
| Dec 2022 | 935,061,000 | 36,195,000 | 28,067,000 | 1,321,258,000 | 874,111,000 | 447,147,000 | 281,781,000 |
TTM Snapshot
Revenues TTM
$82,630,000
NetIncome TTM
$8,211,000
OpCashFlow TTM
$0
Assets (Latest)
$439,831,000
Forward EPS
$6.38
Max Pain — expiry 2026-10-16
max pain strike: $75.00 · spot: $99.74 · call oi: 2,144 · put oi: 482
Expected Move to 2026-10-16:
±$1.95
(1.96%) —
implied range
$97.79 –
$101.69
· ATM straddle on $100.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ICLR | ICON PLC | $13.30B | $172.33 | — |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $14.11B | $292.84 | — |
| NEOG | NEOGEN CORP | $3.00B | $13.76 | — |
| MEDP | Medpace Holdings, Inc. | $17.27B | $618.88 | — |
| CLDX | Celldex Therapeutics, Inc. | $2.44B | $31.10 | — |
News headlines (Yahoo Finance, 1h cache)
Lantheus Announces First Patient Dosed in SPARROW Phase 2/3 Registrational Trial in Prostate Cancer
2026-09-28 12:00 · Yahoo
Lantheus Holdings (LNTH) Could Be 7% Undervalued On BRAVNETSA Approval
2026-09-26 18:10 · Yahoo
Lantheus Holdings (LNTH) Stock May Be 14% Undervalued On FDA Approval
2026-09-26 02:08 · Yahoo
3 Reasons LNTH is Risky and 1 Stock to Buy Instead
2026-09-23 13:57 · Yahoo
Lantheus Receives Final FDA Approval for BRAVNETSA™ (Lutetium Lu 177 Dotatate), the Only Radiopharmaceutical FDA has Determined to be Bioequivalent and Therapeutically Equivalent to LUTATHERA® for the
2026-09-22 12:00 · Yahoo
2 Small-Cap Stocks to Consider Right Now and 1 That Underwhelm
2026-09-11 23:55 · Yahoo
Curium acquisition of Lantheus backed by $5.375B of debt financing
2026-08-26 20:56 · Yahoo
Lantheus Announces FDA Approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer’s Disease
2026-08-14 12:00 · Yahoo
Lantheus Reports Second Quarter 2026 Financial Results
2026-08-06 11:00 · Yahoo
1 Healthcare Stock Worth Your Attention and 2 We Question
2026-08-04 05:01 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.